OPEN Foundation

First MDMA/PTSD trial finished

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

The first finished clinical trial regarding PTSD (post-traumatic stress disorder) and the treatment of that disorder with MDMA has indicated that MDMA can relieve PTSD symptoms: over 80 percent of the participants no longer met the requirements for PTSD as they are defined in DSM-IV (the most recent ‘handbook’ for mental disorders).

The study focused on two therapy sessions of eight hours with a period of three to five weeks in between. Some of the participants were given MDMA, the others were given a placebo. All participants also took part in weekly ‘normal’ psychotherapy sessions. Ten out of the twelve people that were given MDMA reacted positively on the treatment.

After two months, the people from the control group were given the opportunity to take part in the real treatment, where they would be given MDMA this time. Seven out of eight people from the control group chose to do this, with positive results. It seems as if there has been a breakthrough in researching psychotherapy with the aid of MDMA, making room for new studies – which is good news!

OPEN Foundation

INTERESTED IN PSYCHEDELIC RESEARCH AND THERAPIES?

Subscribe to the OPEN Foundation’s newsletter to stay in the loop, hear about our events, and become a part of a community dedicated to advancing psychedelics.

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.